Treatment of Acute Hepatitis C Virus in HIV Co-Infection

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to test the hypothesis that treatment of hepatitis C virus (HCV) infection during the first 6 months after acquiring HCV among people who already have pre-existing HIV infection will result in improved responses to HCV therapy with a shorter duration of infection.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, San Francisco
• Collaborator: California HIV/AIDS Research Program
• Treatments: Interferon alpha-2; Interferon-alpha; Interferons; Peginterferon alfa-2a; Ribavirin

Criteria

Inclusion Criteria:

• Newly acquired HCV infection of 6 months or less duration

• Detectable HCV RNA at study entry

• HIV infection, any CD4 count

Exclusion Criteria:

• Pregnant or intent to become pregnant within 24 weeks of study completion

• Uncontrolled depression

• Other serious liver disease

• Other safety parameters must be met